A multicenter, double-blind, randomized, placebo controlled comparison of the effects on sexual functioning of extended-release bupropion hydrochloride (300-450mg) and escitalopram (10-20mg) in outpatients with moderate to severe major depression over an eight-week treatment period

Trial Profile

A multicenter, double-blind, randomized, placebo controlled comparison of the effects on sexual functioning of extended-release bupropion hydrochloride (300-450mg) and escitalopram (10-20mg) in outpatients with moderate to severe major depression over an eight-week treatment period

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Mar 2010

At a glance

  • Drugs Bupropion; Escitalopram
  • Indications Depression; Major depressive disorder
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 04 Nov 2008 Checked against ClinicalTrials.gov record.
    • 01 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top